The Prognostic Value of Perineural and Angiolymphatic Invasion in Non-metastasised Invasive Bladder Carcinoma

Author： Schrier B.P H.   Speel T.   Hulsbergen-Van De Kaa C.A.   Witjes J.A.  

Publisher： Ashgate Publishing Ltd

ISSN： 1561-0950

Source： UroOncology, Vol.2, Iss.2, 2002-01, pp. : 71-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational therapies for non-muscle invasive bladder cancer

By Smaldone Marc C   Casella Daniel P   Welchons Daniel R   Gingrich Jeffrey R  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 3, 2010-03 ,pp. : 371-383

Informa Healthcare

Access to resources Recommend Favorite

Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer

By Yutkin Vladimir   Chin Joseph  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 251-260

Informa Healthcare

Access to resources Recommend Favorite

Biomarkers of Aging with Prognostic and Predictive Value in Non-Oncological Diseases

By  

Current Medicinal Chemistry, Vol. 16, Iss. 27, 2009-09 ,pp. : 3469-3475

Bentham Science Publishers

Access to resources Recommend Favorite

Prognostic Role of P27kip1 and Epidermal Growth Factor Receptor in Transitional Cell Carcinoma of the Bladder

By Valentine Andrea   Ritchie Joan L.   Nevin Gerald B.   McKeown Stephanie R.  

UroOncology, Vol. 2, Iss. 1, 2002-01 ,pp. : 41-46

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Significance of Fragile Histidine Triad Protein as a Molecular Prognostic Marker of Bladder Urothelial Carcinoma

By Zhang CT   Lu R   Lin YL   Liu RL   Zhang ZH   Yang K   Dang RF   Zhang HT   Shen YG   Kong PZ   Ren HL   Li XL   Quan W   Xu Y  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 507-516

Field House Publishing

Access to resources Recommend Favorite